VIR
Vir Biotechnology·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
VIR Profile
Vir Biotechnology, Inc.
A biotech company developing innovative treatments for infectious diseases, including hepatitis B and COVID-19
1800 Owens Street, Suite 900, San Francisco, California 94158
--
Vir Biotechnology, Inc., was incorporated under the laws of the State of Delaware on April 7, 2016. The company is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious diseases, including virus-related diseases. The company aims to achieve this in two basic ways — first, by developing powerful antibody therapies, and second, by generating unique T-cell responses in vivo through a T-cell-based viral vector platform.
